Intrinsic Value of S&P & Nasdaq Contact Us

Lyra Therapeutics, Inc. LYRA

NASDAQ Global Market

SharesGrow Score
34/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.50
+13.6%

Lyra Therapeutics, Inc. (LYRA) current share price is $0.44. The gold spot price is $4,825.20 per troy ounce. Using the formula: LYRA in gold = $0.44 × 31.1035 ÷ $4,825.20 = 0.0028 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of LYRA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding LYRA shares over the measured period.

LYRA in US Dollars
Gold in US Dollars
LYRA in Gold (grams per share)

Real Wealth Growth Rate

LYRA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{LYRA}_{\text{gold}}(t) = \frac{P_{\text{LYRA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{LYRA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{LYRA}_{\text{gold}}^{(T)}}{\text{LYRA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{LYRA}_\text{gold}^{(0)}$ = initial gold-price, $\text{LYRA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
CGEM
CGEM
Cullinan Oncology, Inc.
$14.35
+0.70%
CTMX
CTMX
CytomX Therapeutics, Inc.
$4.54
+3.42%
ASMB
ASMB
Assembly Biosciences, Inc.
$29.44
+0.68%
AUTL
AUTL
Autolus Therapeutics plc
$1.50
+2.04%
SPRO
SPRO
Spero Therapeutics, Inc.
$2.78
-0.36%
ACHL
ACHL
Achilles Therapeutics plc
$1.48
+0.68%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message